"Our focus is not just on enabling weight loss, but on delivering holistic, medically guided outcomes that balance fat loss with muscle health." According to market research firm PharmaTrac, the semaglutide market is poised for massive expansion with the obesity drug segment projected to grow to 8,000 crore by 2030 from approximately 1,500 crore at present
Another study based on the same clinical trial found that participants who were prescribed semaglutide lost an average of 10.2% of their body weight and 7.7cm from their waist over a four-year period, while the placebo group lost 1.5% of body weight and 1.3cm from the waist
The ozempic questionnaire screens: Have you ever been diagnosed with or do you currently suffer from an eating disorder such as anorexia or bulimia? Eating disorder history requires psychological assessment and may contraindicate treatment or require specialist co-management
The earliest realistic launch is 2036 to 2037, and that assumes the regulatory pathway is settled in advance
Upper GI bleeding can occur without strong pain
If they form, they can hurt your cells